Green Tea Extract (EGCG) 관련 산화 스트레스 및 신경염증
C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.Research suggests EGCG inhibits beta-amyloid aggregation and provides antioxidant neuroprotection. Strong epidemiological data links regular green tea consumption to reduced cognitive decline risk.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Dgreen\u002Dtea\u002Dextract\u0026condition\u003Doxidative\u002Dneuroinflammation';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
결론
Research suggests EGCG inhibits beta-amyloid aggregation and provides antioxidant neuroprotection. Strong epidemiological data links regular green tea consumption to reduced cognitive decline risk.
Key Study Findings
Review
Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: older adults and individuals with neurodegenerative disorders
Review
Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.
Dose: None
vs: None
Outcome: ASD symptom management
효과: None
None
대상 집단: Children with autism spectrum disorder
Review
Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support.
Dose: None
vs: None
Outcome: Neuroprotection in Alzheimer's disease
효과: None
None
대상 집단: Alzheimer's disease (review with in silico)
Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Other
5 weeks
Mitigating Age-Related Cognitive Decline and Oxidative Status in Rats Treated with Catechin and Polyphenon-60.
Dose: None
vs: None
Outcome: Cognitive function
효과: None
None
대상 집단: Rat model
Review
Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic …
Dose: Various phytochemicals
vs: None
Outcome: Neuroprotection in aging and neurodegeneration
효과: None
None
대상 집단: Aging brain and NDD models (review)
Key Statistics
10
연구
800
참여자
↑
Positive
C
등급
Referenced Papers
Phytotherapy research : …
2026
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Review
Nutritional neuroscience
2025
14 인용
Food science & …
2025
4 인용
Alternative therapies in …
2025
Nutrients
2024
8 인용
Nutrients
2023
31 인용
Frontiers in pharmacology
2022
51 인용
Molecular neurobiology
2021
22 인용
Molecular nutrition & …
2021
18 인용
European journal of …
2020
91 인용
Neurochemistry international
2016
153 인용
The Journal of …
2014
33 인용
Evidence-based complementary and …
2012
93 인용
Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis.
Review
Clinical nutrition (Edinburgh, …
2009
52 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 250-500 mg/day EGCG
- viatea:
- 3-5 cups/day
상한량: 800 mg/day EGCG from supplements (hepatotoxicity risk above)
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | 5 weeks | Positive | -- |
| Various phytochemicals | -- | Positive | -- |
| None | -- | Positive | -- |
| None | 8 weeks | Positive | -- |
권장 복용 시간: Between meals; avoid on empty stomach
Safety & Side Effects
보고된 부작용
- ⚠ Liver toxicity at high doses (>800 mg EGCG/day)
- ⚠ Insomnia (caffeine content)
- ⚠ Gastrointestinal discomfort
- ⚠ Iron absorption reduction
알려진 상호작용
- ● Iron supplements (tannins reduce absorption)
- ● Nadolol (reduces blood levels)
- ● Blood thinners (mild antiplatelet effect)
- ● MAO inhibitors (caffeine interaction)
일일 최대 섭취 허용량: 800 mg/day EGCG from supplements (hepatotoxicity risk above)
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Green Tea Extract (EGCG) help with 산화 스트레스 및 신경염증?
Based on 10 studies with 800 participants, there is limited but promising evidence that Green Tea Extract (EGCG) may support 산화 스트레스 및 신경염증 management. Our evidence grade is C (Some Evidence).
How much Green Tea Extract (EGCG) should I take for 산화 스트레스 및 신경염증?
Studies have used various dosages. A commonly studied range is 250-500 mg/day EGCG. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Green Tea Extract (EGCG)?
Reported side effects may include Liver toxicity at high doses (>800 mg EGCG/day), Insomnia (caffeine content), Gastrointestinal discomfort, Iron absorption reduction. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Green Tea Extract (EGCG) and 산화 스트레스 및 신경염증?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: 산화 스트레스 및 신경염증
References
- [1] Lei Wang et al.. Phytother Res. 2026. Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and Their Association With Cognitive Function … doi:10.1002/ptr.70198 PubMed
- [2] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
- [3] Guifei Chen et al.. Food Sci Nutr. 2025. Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. doi:10.1002/fsn3.70496 PubMed
- [4] Nasser M Aldekhail et al.. Altern Ther Health Med. 2025. Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. PubMed
- [5] Silvia Tejada et al.. Nutrients. 2024. Mitigating Age-Related Cognitive Decline and Oxidative Status in Rats Treated with Catechin and Polyphenon-60. doi:10.3390/nu16030368 PubMed
- [6] Hamid Mostafavi Abdolmaleky et al.. Nutrients. 2023. Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals. doi:10.3390/nu15153456 PubMed
- [7] Yumin Wang et al.. Front Pharmacol. 2022. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease. doi:10.3389/fphar.2022.977521 PubMed
- [8] Belén Mollá et al.. Mol Neurobiol. 2021. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model. doi:10.1007/s12035-021-02285-1 PubMed
- [9] Zhipeng Kan et al.. Mol Nutr Food Res. 2021. Green Tea Suppresses Amyloid β Levels and Alleviates Cognitive Impairment by Inhibiting APP Cleavage and Preventing Neurotoxicity in 5XFAD Mice. doi:10.1002/mnfr.202100626 PubMed
- [10] Danica Michaličková et al.. Eur J Pharmacol. 2020. Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. doi:10.1016/j.ejphar.2020.172973 PubMed
- [11] Madhuri Venigalla et al.. Neurochem Int. 2016. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. doi:10.1016/j.neuint.2015.10.011 PubMed
- [12] Marcos H Okuda et al.. J Nutr Biochem. 2014. Green tea extract improves high fat diet-induced hypothalamic inflammation, without affecting the serotoninergic system. doi:10.1016/j.jnutbio.2014.05.012 PubMed
- [13] Kuo-Jen Wu et al.. Evid Based Complement Alternat Med. 2012. Green Tea Extract Ameliorates Learning and Memory Deficits in Ischemic Rats via Its Active Component Polyphenol Epigallocatechin-3-gallate by Modulation of … doi:10.1155/2012/163106 PubMed
- [14] Barkha P Patel et al.. Clin Nutr. 2009. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. doi:10.1016/j.clnu.2009.06.002 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.